Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
about
Personalized medicine and treatment approaches in hypertension: current perspectivesGenetics of resistant hypertension: a novel pharmacogenomics phenotypePharmacogenomics of hypertension and heart diseaseHypertension pharmacogenomics: in search of personalized treatment approachesNew Developments in the Genetics of Hypertension: What Should Clinicians Know?Pharmacogenomics considerations in the control of hypertension.Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide.Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses.Personalized medicine-a modern approach for the diagnosis and management of hypertension.Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension.Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics.Hypertension genomics and cardiovascular prevention
P2860
Q26751135-FB10A3D4-6E56-4030-A1CA-5E1567ED7EF2Q26851506-CC27F3B9-EFF3-48B7-859E-CAC20CC08125Q27015722-8C951C3C-1384-4E18-9F95-D51C6BFD095CQ36652960-000E1F15-C4C8-4D78-881D-05617E1505FEQ38621418-F2AC5670-8418-4E19-BBDD-5A4EEBBF324EQ38629883-4755A07C-0DE4-4668-9E6F-8D2FB1117B05Q38801250-3F5DA1D6-A37E-4F0F-B51E-3988D617BA98Q40269056-80E443AB-7E58-4AD7-A6B1-C82B1F85C3D6Q47095825-A5A03111-88BD-4CFD-964F-0842C50D3DC3Q47137466-A580D4B5-D246-482E-9049-11E2404D8E87Q47168939-EBDEA39A-465C-4287-83D2-89EFB93610B4Q47193469-005CAEB7-93F5-4FF3-8CCD-A374980E5D94Q58804798-BD10E338-F308-4EE5-B6DF-18D373063834
P2860
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@ast
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@en
type
label
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@ast
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@en
prefLabel
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@ast
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@en
P2093
P2860
P50
P356
P1476
Pharmacogenomics of hypertensi ...... ses of antihypertensive drugs.
@en
P2093
Antti-Pekka Sarin
Arlene B Chapman
Francesca Frau
John G Gums
Julie A Johnson
Kati M Donner
Kimmo K Kontula
Nicola Glorioso
Rhonda M Cooper-DeHoff
Roberta Zaninello
P2860
P304
P356
10.1161/JAHA.114.001521
P577
2015-01-26T00:00:00Z